Fujii, Y. et al., “Biological Overview of HIV Accessory Protein Nef,” Saibo Kogaku, 1997, pp. 94-99, vol. 16, No. 1. |
Liu et al., “Binding of HIV-1 Nef to a novel thioesterase enzyme correlates with Nef-mediated CD4 down-regulation”, The Journal of biological Chemistry, 1997, pp. 13779-13785, vol. 272. |
Cawthon et al., “cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromtosis type 1 gene”, Genomics, 1991, pp. 446-460, vol. 9. |
Ahn et al., “The structural and functional diversity of dystophin”, Nature Genetics, 1993, pp. 283-291, vol. 3. |
Okada, H., et al., “Inhibition of HIV-1 Nef induced apoptosis of uninfected human blood cells by serine/threonine protein kinase inhibitors, fasudil hydrochloride and M3”, Febs Letters, Feb. 6, 1998, PPS. 363-367, vol. 422, No. 3, XP002115665, Amsterdam, NL. |
Luo T., et al., “Infectivity enhancement by immunodeficiency virus type 1 Nef is independent of its association with a cellular serine/threonine kinase”, Journal of Virology, 1997, pp. 9524-9530, vol. 71, No. 12, XP002115666, US. |
Rossi, F., et al., “HsN3 proteasomal subunit as a target for human immunodeficiency virus type 1 Nef protein”, Virology, 1997, pp. 33-45, vol. 237, No. 1, XP002115667, Orlando, US. |
Smith, B.L., et al., “The HIV Nef protein associates with protein kinase C theta”, Journal of Biological Chemistry, 1996, pp. 16753-16757, vol. 271, No. 28, XP002115668, MD, US. |
De Reuck, et al., “A double-blind study of neurotropin in patients with acute ischemic stroke,” Acta Neurol Scand, 1994, pp. 329-335, 89. |